Horizon Kinetics’s Pacific Biosciences PACB Stock Holding History

Horizon Kinetics’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$89K	Hold	12,000	–	–	﹤0.01%	457
2018 Q3	$65K	Hold	12,000	–	–	﹤0.01%	497
2018 Q2	$43K	Hold	12,000	–	–	﹤0.01%	504
2018 Q1	$25K	Hold	12,000	–	–	﹤0.01%	505
2017 Q4	$32K	Hold	12,000	–	–	﹤0.01%	494
2017 Q3	$63K	Hold	12,000	–	–	﹤0.01%	487
2017 Q2	$43K	Hold	12,000	–	–	﹤0.01%	503
2017 Q1	$62K	Hold	12,000	–	–	﹤0.01%	496
2016 Q4	$46K	Hold	12,000	–	–	﹤0.01%	501
2016 Q3	$108K	Hold	12,000	–	–	﹤0.01%	494
2016 Q2	$84K	Hold	12,000	–	–	﹤0.01%	510
2016 Q1	$102K	Hold	12,000	–	–	﹤0.01%	510
2015 Q4	$158K	Hold	12,000	–	–	﹤0.01%	482
2015 Q3	$44K	Hold	12,000	–	–	﹤0.01%	495
2015 Q2	$69K	Hold	12,000	–	–	﹤0.01%	511
2015 Q1	$70K	Hold	12,000	–	–	﹤0.01%	513
2014 Q4	$94K	Hold	12,000	–	–	﹤0.01%	508
2014 Q3	$59K	Hold	12,000	–	–	﹤0.01%	515
2014 Q2	$74K	Hold	12,000	–	–	﹤0.01%	526
2014 Q1	$64K	Hold	12,000	–	–	﹤0.01%	529
2013 Q4	$63K	Hold	12,000	–	–	﹤0.01%	534
2013 Q3	$66K	Hold	12,000	–	–	﹤0.01%	535
2013 Q2	$30K	Buy	+12,000	New	+$29.9K	﹤0.01%	459

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Horizon Kinetics's PACB Position: Q4 2018 in Review

Horizon Kinetics held its Pacific Biosciences (PACB) position steady in Q4 2018 at 12,000 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

Horizon Kinetics first reported a position in PACB in Q2 2013 and has held it in 23 quarters since. The position peaked at $158K in Q4 2015. 155 funds tracked by Wall St. Rank hold PACB as of Q4 2018.

Horizon Kinetics held 12,000 shares of Pacific Biosciences worth $89K as of Q4 2018.
Horizon Kinetics left its Pacific Biosciences share count unchanged in Q4 2018.
Pacific Biosciences made up ﹤0.01% of Horizon Kinetics's portfolio in Q4 2018, its #457 holding.
Horizon Kinetics first reported a position in Pacific Biosciences in Q2 2013 and has held it in 23 quarters since.
Horizon Kinetics's Pacific Biosciences position peaked at $158K in Q4 2015.
155 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.